Although urinary problems are common before your prostate cancer diagnosis — from dribbling urine to trouble passing urine due to an enlarged prostate, many men still find themselves having bladder difficulties after surgery or radiation therapy. Here at our prostate health center, we encourage patients to be more watchful of their urinary habits following treatment.
By and large, the following urinary difficulties may be encountered surgery and radiation therapy:
- blood in the urine
- a sensation of wanting to pass urine multiple times at night
- poor flow of urine
- urinary incontinence
- bladder irritation and a burning sensation when passing urine (specific to radiation therapy)
Urinary incontinence commonly occurs following either surgery and radiation therapy, albeit temporarily. Most cases of incontinence get better with time and permanent cases are quite rare these days.
Recurrent Prostate Cancer Treatment
Recurrent prostate tumors after failed radiotherapy (Cyberknife, IMRT or Proton Beam Therapy) or HIFU (High Intensity Focused Ultrasound) can be difficult to detect due to dramatic changes in prostate gland architecture that occur secondary to treatment. Recurrent tumors can be quite small, but with a 3T Multi-Parametric MRI – BlueLaser™ and 3T Multi-Parametric MRI – BlueLaser™ Guided Biopsy early detection is possible.
Dan Sperling, MD is a premier authority and pioneer in the use of MRI-Guided prostate imaging. His groundbreaking work at The Sperling Prostate Center represents a new paradigm in both the detection and treatment of prostate cancer. Call us now at 877-605-2737 or fill out this contact form to request a consultation. We look forward to helping you improve your prostate health!
About Dr. Dan Sperling
Dan Sperling, MD, DABR, is a board certified radiologist who is globally recognized as a leader in multiparametric MRI for the detection and diagnosis of a range of disease conditions. As Medical Director of the Sperling Prostate Center, Sperling Medical Group and Sperling Neurosurgery Associates, he and his team are on the leading edge of significant change in medical practice. He is the co-author of the new patient book Redefining Prostate Cancer, and is a contributing author on over 25 published studies. For more information, contact the Sperling Prostate Center.
